The First Hospital of Jilin University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1920-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bethune-jilin.cn
Epidemiological Survey of Hepatitis D Virus Infection in China
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 5000
- Registration Number
- NCT04483518
- Locations
- 🇨🇳
the first hospital of Jilin University, Changchun, Jilin, China
Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 170
- Registration Number
- NCT04460508
- Locations
- 🇨🇳
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 46
- Registration Number
- NCT04397107
- Locations
- 🇨🇳
Sirui Yang, Changchun, Changchun/Jilin, China
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 59
- Registration Number
- NCT04387942
- Locations
- 🇨🇳
Sirui Yang, Changchun, Changchun/JiLin, China
Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 30
- Registration Number
- NCT04326153
- Locations
- 🇨🇳
The First Hospital Of Jilin University, Changchun, Jilin, China
Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 100
- Registration Number
- NCT04063189
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 8
- Registration Number
- NCT04034368
Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 40
- Registration Number
- NCT03998085
- Locations
- 🇨🇳
First Hospital of Jilin University, Chang chun, Jilin, China
Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 20
- Registration Number
- NCT03958097
- Locations
- 🇨🇳
First Hospital of Jilin University, Chang chun, Jilin, China
Efficacy of Two Intermittent Subglottic Secretion
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2019-03-12
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 234
- Registration Number
- NCT03871985
© Copyright 2024. All Rights Reserved by MedPath